HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assunta Pandolfi Selected Research

N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamine

1/2018Calcimimetic R-568 vasodilatory effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs).
1/2013Calcium sensing receptor expression in ovine amniotic fluid mesenchymal stem cells and the potential role of R-568 during osteogenic differentiation.
1/2012Calcimimetic R-568 and its enantiomer S-568 increase nitric oxide release in human endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Assunta Pandolfi Research Topics

Disease

13Inflammation (Inflammations)
06/2021 - 10/2005
10Insulin Resistance
06/2021 - 11/2005
7Atherosclerosis
01/2020 - 08/2003
5Hyperglycemia
06/2021 - 07/2007
5Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2004
5Type 2 Diabetes Mellitus (MODY)
01/2020 - 12/2006
4Gestational Diabetes (Gestational Diabetes Mellitus)
06/2021 - 11/2017
3Chronic Kidney Failure (Chronic Renal Failure)
06/2016 - 05/2005
3Myocardial Infarction
08/2013 - 12/2011
2Osteoporosis
08/2021 - 07/2021
2Pediatric Obesity
01/2021 - 01/2017
2Coronary Disease (Coronary Heart Disease)
10/2020 - 08/2013
2Uremia
06/2016 - 07/2011
2Obesity
02/2016 - 12/2011
2Genetic Predisposition to Disease (Genetic Predisposition)
07/2008 - 01/2004
2Hyperinsulinism (Hyperinsulinemia)
07/2007 - 11/2005
2Diabetes Mellitus
07/2007 - 12/2006
1Myopia
01/2022
1Bone Resorption
07/2021
1Rheumatoid Arthritis
07/2021
1Bone Fractures (Bone Fracture)
07/2021
1Vascular Calcification
04/2021
1Neoplasms (Cancer)
01/2021
1Dyslipidemias (Dyslipidemia)
01/2020
1Glioma (Gliomas)
05/2018
1Hypertension (High Blood Pressure)
01/2018
1Blister (Bulla)
12/2017
1Alzheimer Disease (Alzheimer's Disease)
01/2016
1Intellectual Disability (Idiocy)
01/2016
1Atherosclerotic Plaque (Atheroma)
01/2016
1Cognitive Dysfunction
01/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016
1Heart Valve Diseases (Valvular Heart Disease)
01/2015
1Down Syndrome (Down's Syndrome)
10/2014
1Aneuploidy (Aneuploid)
10/2014
1Pathologic Constriction (Stenosis)
08/2013

Drug/Important Bio-Agent (IBA)

9Insulin (Novolin)FDA Link
01/2017 - 01/2004
8Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017 - 08/2003
5Glucose (Dextrose)FDA LinkGeneric
06/2021 - 08/2012
5AntioxidantsIBA
01/2021 - 03/2008
5Biological ProductsIBA
01/2020 - 07/2008
4Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2005
3Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2017
3Carotenoids (Carotene)IBA
01/2020 - 02/2012
3N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamineIBA
01/2018 - 01/2012
3PhosphatidylserinesIBA
06/2016 - 05/2005
3Nitric Oxide Synthase (NO Synthase)IBA
01/2013 - 05/2005
3Messenger RNA (mRNA)IBA
07/2011 - 05/2005
2LycopeneIBA
01/2019 - 02/2012
2Guanosine Monophosphate (5' Guanylic Acid)IBA
06/2016 - 02/2012
2Pharmaceutical PreparationsIBA
01/2016 - 10/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2012 - 02/2009
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2012 - 12/2007
2Annexin A5IBA
12/2007 - 05/2005
1VitaminsIBA
08/2021
1AcetoneIBA
07/2021
1AcidsIBA
07/2021
1Fatty Acids (Saturated Fatty Acids)IBA
07/2021
1Inositol (Myoinositol)IBA
06/2021
1Vitamin K 2 (Vitamin K2)IBA
04/2021
1Sirtuin 1IBA
01/2021
1NAD (NADH)IBA
01/2021
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021
1Oxidants (Oxidizing Agents)IBA
01/2021
1Cyclin-Dependent Kinase Inhibitor p16IBA
01/2021
1Pyruvaldehyde (Methylglyoxal)IBA
10/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020
1PolyphenolsIBA
01/2020
1Fibric Acids (Fibrates)IBA
01/2020
1LipidsIBA
01/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2020
1Fenofibrate (CiL)FDA LinkGeneric
01/2020
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2018
1prolinamideIBA
05/2018
1ovothiol A (U23)IBA
01/2018
1CateninsIBA
12/2017
1VinculinIBA
12/2017
1PaxillinIBA
12/2017
1cadherin 5IBA
12/2017
1Glucagon-Like Peptide-1 ReceptorIBA
11/2017
1LiraglutideFDA Link
11/2017
1lipoxin A4IBA
01/2017
1Calmodulin (Calcium-Dependent Activator Protein)IBA
06/2016
1CalciumIBA
06/2016
1IonomycinIBA
06/2016
1Membrane Transport Proteins (Biological Pump)IBA
06/2016
1CholesterolIBA
02/2016
1Triglycerides (Triacylglycerol)IBA
02/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1low density lipoprotein inhibitorIBA
01/2016
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2016
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2016
1oxidized low density lipoproteinIBA
01/2016
1XylitolIBA
01/2016
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2016
1Glutamic Acid (Glutamate)FDA Link
08/2013

Therapy/Procedure

4Therapeutics
08/2021 - 05/2018
1Operative Surgical Procedures
01/2022
1Prostheses and Implants (Prosthesis)
01/2015
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2013